Clinical Trial Update: T Cells Expressing HER2-specific Chimeric Antigen Receptors(CAR) for Patients With HER2-Positive CNS Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial of HER2-specific CAR-T cells for HER2-positive brain tumors; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms

Drugs mentioned

• HER2-specific CAR-T cells

Snippet

Sponsor: Baylor College of Medicine | Conditions: Brain Tumor, Recurrent, Brain Tumor, Refractory | Phase 1 | Status: ACTIVE_NOT_RECRUITING